![]()
- Citigroup Lost $20 Million on Facebook IPO Trades
- Sticker Shock: What College Is Likely to Cost in 18 Years
- Icahn Raises Stake in Chesapeake, Wants Board Seats
- Week Ahead: Europe Has Wall Street Bull on Short Leash
- What Happened to Stocks? Most Unloved in 50 Years
- Break Up JPMorgan: Sheila Bair

- Main Players in the Greek Election
- Many Greeks Moved Their Money Abroad Long Ago
- Bankia Asks Spain for $24 Billion Bailout
- A New Look at the ‘New Poor’
- Six Pack: Beer Buzz of the Week
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Under Pressure, FHA Skews to Wealthier Home Buyers
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Yoshikami: Four Things You Need to Know About Gold Now
- Steinbock: The Euro Zone Endgame Begins
- Option Bulls Take Another Shot on Idenix
MOST SHARED
- Citigroup Lost $20 Million on Facebook IPO Trades
- Spanish Lender Seeks 19 Billion Euros; Ratings Cut on 5 Banks
- Astronauts Snare SpaceX Rocket
- Carl Icahn Increases Stake in Chesapeake, Demands Board Seats
- Marc Faber: 100% Chance of Global Recession
- The Key to a Successful Turnaround
- Your First Move For Tuesday May 29th
- Oil Declines, but Doesn't Help European Consumers
- Senate Summons Dimon to 'Get to the Bottom' of JPM Mess
- Kansas City Fed President Steps Into Jamie Dimon Debate
MOST POPULAR
HOT ON FACEBOOK
Hot Stocks: Alnylam, Green Energy Plays Among Monday's Movers
Big contract wins and corporate dealmaking were some of the catalysts behind Monday's most actively traded stocks.
Shares of Alnylam Pharmaceuticals [ALNY
Loading...
()
] jumped more than 50% after the tiny drug developer said it inked a deal with Swiss drug giant Roche to develop Alnylam's gene-silencing technology in order to fight diseases.
The deal, which has Roche making an upfront payment of $338 million with the potential for future milestone payments of $1 billion, is one of the largest in the nascent but promising research area. Alnylam rival Sirna Therapeutics was acquired by Merck [MRK
Loading...
()
] earlier this year for more than $1.1 billion.
Green energy outfit First Solar [FSLR
Loading...
()
] surged to new all-time highs on Monday after the company said it signed new contracts which should result in future sales of more than $1.2 billion. Tiny energy company Beacon Power [BCON
Loading...
()
], which is developing "flywheel technology" in order to harness kinetic energy, also saw shares move higher on Monday.
Schnitzer Steel Industries [SCHN
Loading...
()
] gained after the steelmaker reported strong quarterly results on Monday morning. The positive results came in ahead of an earnings update from basic materials giant Alcoa [AA
Loading...
()
] set for release Monday after the close of trading.
Sigmatel [SGTL
Loading...
()
] shares saw big gains after the specialty chipmaker boosted second-quarter guidance, citing improved sales across the board. The Austin, Tex.-based company now expects second-quarter sales in a range of $30 to $31 million, compared with previous guidance of $24 to $28 million.
"We believe we have strong momentum going into the third quarter and are looking forward to sharing more good news during our second quarter conference call," Chief Executive Phil Pompa said in a prepared statement. Sigmatel said it will host the call later this week.
Peter Kang is a markets writer at CNBC.com and can be reached at .
- The Nasdaq has suffered the most from the EU crisis showing there's risk in the usual tech stocks.
- Targeting more Millennials is just one of the items brewing for consumers in the world of spirits.
- It seems many people may need a reminder of how NOT to act on a plane. Here are a few tips.
- Here are some very unusual roadside stops along American highways that might peek your interest.
- How three generations of Americans are dealing with the finances of retirement.











